LOGIN  |  REGISTER
Chimerix
Compass Therapeutics

CareCloud's EHR System Earns High Praise in business.com Review for its Customization Options and User-Friendly Interface

April 25, 2023 | Last Trade: US$1.08 0.0069 -0.63

SOMERSET, N.J., April 25, 2023 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced that business.com published a review of CareCloud's electronic health record (EHR) system Charts, providing an in-depth analysis of the platform's features, usability, and overall value for healthcare providers.

The business.com editor awarded CareCloud Charts an 8.9 out of 10, highlighing its user-friendly interface, which is designed to be intuitive and easy to navigate. The system's robust reporting and analytics capabilities enable providers to gain valuable insights into patient care and practice performance. The review also notes that Charts is highly customizable, offering a range of templates and workflows that can be tailored to the specific needs of individual practices and integrates seamlessly with third-party applications to allow for streamlined data exchange and improved interoperability.

"As the healthcare industry has shifted towards electronic health records, most everyone has a system in place, but not all are using them to their fullest capabilities," said Iram Fatima, M.B.B.S., CareCloud’s chief operating officer for electronic health records and digital health. "That's where CareCloud's EHR solution comes in. We created an EHR system that simplifies the process and helps medical practices take full advantage of the benefits of an EHR. Our goal is to empower providers with the tools they need to deliver better patient care and improve practice performance."

Charts is just one of the many healthcare technology solutions offered by the company. CareCloud is committed to providing healthcare providers with technology-enabled solutions that enhance every aspect of a medical practice, including technology-enabled revenue cycle management (RCM). The tools within CareCloud’s comprehensive suite of solutions are designed to streamline billing processes, increase collections, and improve financial performance. Through its EHR system and other healthcare technology solutions, CareCloud aims to empower medical practices with the tools they need to deliver high-quality patient care while achieving greater efficiency and profitability.

To learn more about CareCloud’s comprehensive suite of technology-enabled services and solutions, visit carecloud.com/solutions.

About CareCloud

CareCloud (Nasdaq: CCLD, CCLDP, CCLDO) brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at www.carecloud.com.

Follow CareCloud on LinkedInTwitter and Facebook.

Company Contact:
Bill Korn
Chief Financial Officer
CareCloud
This email address is being protected from spambots. You need JavaScript enabled to view it.

Investor Contact:
Asher Dewhurst
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.

Media Inquiries:
Alexis Feinberg
ICR Westwicke
This email address is being protected from spambots. You need JavaScript enabled to view it.

Stock Quote

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

Featured Stock

Surmodics

Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic immunoassay tests and microarrays. Surmodics is pursuing highly differentiated whole-product solutions that are designed to address...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB